News Archives for November 2018

Recent News

ASGCT Statement on Germline Gene Editing Practices
November 26, 2018
Position Statements

The American Society of Gene & Cell Therapy (ASGCT) considers it wholly unacceptable to use germline gene-editing and the implantation of gene-edited embryos to achieve a pregnancy without extensive research into the safety, efficacy, and legality of such applications. Any announcements of, or claims to have begun suchstudies in germline gene editing are compromised, both ethically and scientifically.

Key Advances in Gene Therapy and the Promise for Patients
November 19, 2018

ASGCT partnered with the Bipartisan Policy Center and the Alliance for Regenerative Medicine to identify six key areas to focus our work as part of a leadership summit representing patients, industry, scientists, payers, the investment community, as well as federal government officials, including FDA’s CBER Director Peter Marks.

ASGCT Giving Tuesday and It's (Probably) Time to Renew Your Membership
November 08, 2018

Don’t miss out on your chance to be part of our collective progress. Act now to ensure your ASGCT membeship is up to date and please consider including ASGCT in your Giving Tuesday efforts.

22nd Annual Meeting
April 29 – May 2 | Washington D.C.